<DOC>
	<DOCNO>NCT02291510</DOCNO>
	<brief_summary>This study compare pharmacokinetics ( PK ) assess safety delayed-release metformin ( Met DR , EFB0027 ) two dosage level , immediate-release metformin ( Met IR , ETB0015 ) , extended-release metformin ( Met XR , ETB0014 ) healthy subject .</brief_summary>
	<brief_title>Assessing PK Met DR , Met IR , Met XR Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . 19 65 ( inclusive ) year old Visit 1 ( Screening ) 2 . Male , female meet follow criterion : 1 . Not breastfeed 2 . Negative pregnancy test result Visit 1 ( Screening ) ( applicable hysterectomized female ) 3 . Surgically sterile , postmenopausal , childbearing potential , practice willing continue practice appropriate birth control entire duration study 3 . Body mass index ( BMI ) 25.0 35.0 kg/m² ( inclusive ) Visit 1 ( Screening ) 4 . Had physical examination clinically significant abnormality judge investigator 5 . Had normal renal function estimate glomerular filtration rate ( eGFR ) ≥90 mL/min/1.73 m² base Modification Diet Renal Disease ( MDRD ) equation 6 . Ability understand willingness adhere protocol requirement 1 . Had clinically significant medical condition judge investigator could potentially affect study participation and/or personal wellbeing , include limited following condition : 1 . Hepatic disease 2 . Gastrointestinal disease 3 . Endocrine disorder ( include diabetes impair glucose tolerance ) 4 . Cardiovascular disease 5 . Central nervous system diseases 6 . Psychiatric neurological disorder 7 . Organ transplantation 8 . Chronic acute infection 9 . Orthostatic hypotension , faint spell blackouts 10 . Allergy hypersensitivity 2 . Had chronic disease require medication adjust past 90 day ( subject could take acute intermittent overthecounter medication Tylenol , need ) 3 . Had major surgery kind within 6 month Visit 1 ( Screening ) 4 . Had history &gt; 6 kg weight change within 3 month Visit 1 ( Screening ) 5 . Had clinical laboratory test ( clinical chemistry , hematology , urinalysis ) abnormality judge investigator clinically significant Visit 1 ( Screening ) 6 . Had physical , psychological , historical finding , investigator 's opinion , would make subject unsuitable study 7 . Had drug treatment affect gastric pH ( prescription overthecounter ) , include antacid medication Rolaids Pepcid within 2 day Visit 1 ( Screening ) 8 . Currently abuse drug alcohol history abuse investigator 's opinion would cause individual noncompliant study procedures 9 . Smoked 10 cigarette per day , 3 cigar per day , 3 pipe per day , use 1 smokeless tobacco per week , use combination tobacco product approximate nicotine dos equivalent 10 cigarette per day 10 . Had donate blood within 3 month date first dose randomize study medication , plan donate blood study 11 . Had receive investigational drug within 2 month ( five halflives investigational drug , whichever great ) date first dose randomize study medication 12 . Had know allergy hypersensitivity component study treatment 13 . Was employ Elcelyx Therapeutics , Inc ( employee , temporary contract worker , designee company )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>